Mandate

Vinge has advised Ambea AB (publ) in connection with its refinancing

Vinge advised Ambea AB (publ), the leading care provider in Scandinavia, in connection with a refinancing in an aggregate amount of SEK 5,000,000,000.

On 31 October 2022 Ambea AB (publ) entered into an unsecured facility agreement with a bank syndicate comprised of three Nordic banks. The new facility agreement has an initial term of three years with a one year extension option and consist of a SEK 4,000,000,000 committed facility and an uncommitted accordion option of SEK 1,000,000,000.

The purpose of the facility agreement is to refinance certain outstanding loans under the previous SEK 4,500,000,000 facility agreement and to increase the Ambea group’s overall financial flexibility.

Vinges team consisted of partner Albert Wållgren together with Josefine Lanker and Sofia Haggren.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024